Pituitary-adrenal physiology during pregnancy

Endocrinologist

Volumn 11, Issue 3, 2001, Pages 159-170

  Keller Wood, Maureen ^a,b,c   Wood, Charles E ^b  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; CORTICOTROPIN RELEASING FACTOR; HYDROCORTISONE; MINERALOCORTICOID RECEPTOR; PLACENTAL PEPTIDE HORMONE; PROGESTERONE;

ADRENAL GLAND; FETOMATERNAL TRANSFUSION; FETUS DEVELOPMENT; FETUS GROWTH; FETUS MATURITY; HOMEOSTASIS; HORMONE RELEASE; HUMAN; HYDROCORTISONE RELEASE; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; LABOR; PREGNANCY; REVIEW; UTERUS CONTRACTILITY;

EID: 0034967618     PISSN: 10512144     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019616-200105000-00002     Document Type: Review

References (170)

1. Blood levels of 17-hydroxycorticosteroids in normal pregnancy
2. Plasma 17-hydroxycorticosteroids in pregnancy
3. The hydrocortisone production in late pregnancy
4. Maternal adrenocorticotropin and cortisol relationships throughout human pregnancy
5. A sequential study of adrenocorticosteroid level in human pregnancy
6. Fetal and maternal secretion rate of cortisol in sheep: Diffusion resistance of the placenta
7. Urinary cortisol excretion in stress situations and in patients with Cushing's syndrome
8. Clinical evaluation of urinary cortisol determinations by competitive protein-binding radioassay
9. Increased exposure of tissues to cortisol in late pregnancy
10. Serum CBG, free and total cortisol and circadian patterns of adrenal function in normal pregnancy
11. Elevated non-protein-bound cortisol (NPC) in pregnancy, during estrogen administration and in carcinoma of the prostate
12. The increase in plasma and saliva cortisol levels in pregnancy is not due to the increase in corticosteroid-binding globulin levels
13. A corticosteroid binding protein in plasma. II. Levels in various conditions and the effects of estrogens
14. Effects of ethynylestradiol on the renin-angiotensin-aldosterone system and on plasma transcortin in women and men
15. Increased plasma concentration of N-terminal beta-lipotrophin and unbound cortisol during pregnancy
16. Elevated free cortisol index in pregnancy: Possible regulatory mechanisms
17. The effect of oral contraceptive use and pregnancy on the daily rhythm of cortisol and cortisone
18. Transcortin: A corticosteroid binding protein of plasma. X. Cortisol and progesterone interplay and unbound levels of these steroids in pregnancy
19. Comparative aspects of cortisol transport: Lack of firm binding to plasma proteins in domestic ruminants
20. Influence of reproductive state on pituitary-adrenal activity in the ewe
21. Pattern of plasma ACTH, hGH, and cortisol during menstrual cycle
22. Possible placental origin of ACTH in normal human pregnancy
23. Plasma cortisol and adrenocorticotrophic hormone in normal men and non-pregnant women, normal pregnant women, and women with pre-eclampsia
24. Adrenal response in pregnancy to long-acting tetracosactrin
25. Corticotropin responses to hypoglycemia and hypotension during pregnancy
26. Changes in the baroreflex during pregnancy in conscious dogs: Heart rate and hormonal responses
27. Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. I. Effect of an audiovisual stimulus and insulin-induced hypoglycemia
28. Hypophysiotropic regulation of adrenocorticotropin secretion in response to insulin-induced hypoglycemia
29. A method for determining baroreflex-mediated sympathetic and parasympathetic control of the heart in pregnant and nonpregnant sheep
30. Changes in baroreceptor sensitivity for heart rate during normotensive pregnancy and the puerperium
31. Variations in the hypothalamic-pituitary-adrenal response to stress during the estrous cycle in the rat
32. Effects of estrogen and estrous cycle on glucocorticoid and catecholamine responses to stress in sheep
33. Effects of a simulated estrous cycle on sodium, volume, ACTH, and AVP in sheep
34. Pituitary responses to synthetic corticotropin-releasing hormone: Absence of modulatory effects by estrogen and progestin
35. Changes in fetal plasma corticotropin-releasing hormone during androstenedione-induced labor in the rhesus monkey: Lack of an effect on the fetal hypothalamo-pituitary-adrenal axis
36. The effects of estrogen and progesterone on corticotropin-releasing hormone and arginine vasopressin messenger ribonucleic acid levels in the paraventricular nucleus and supraoptic nucleus of the rhesus monkey
37. Placental corticotropin-releasing hormone may be a stimulator of maternal pituitary adrenocorticotropic hormone secretion in humans
38. The corticotrophin releasing hormone test in late pregnancy: Lack of adrenocorticotrophin and cortisol response
39. Response to corticotropin-releasing hormone during pregnancy in the baboon
40. Responses to corticotropin-releasing hormone and its bound and free forms in pregnant and nonpregnant women
41. Adrenocorticotropin and cortisol responses to vasopressin during pregnancy
42. ACTH responses to CRF and AVP in pregnant and nonpregnant ewes
43. Hypercortisolism and the resistance to dexamethasone suppression during gestation
44. The effects of repeat doses of antenatal corticosteroids on maternal adrenal function
45. Adrenal suppression induced by betamethasone in women at risk for premature delivery
46. Biologically active corticotropin-releasing hormone in maternal and fetal plasma during pregnancy
47. High precursor level in maternal blood results from the alternate mode of proopiomelanocortin processing in human placenta
48. Postnatal disappearance of the pregnancy-associated reduced sensitivity of plasma cortisol to feedback inhibition
49. Corticotropin-releasing factor in the ovine fetus and pregnant ewe: Role of the placenta
50. Does the ovine placenta secrete ACTH under normoxic or hypoxic conditions?
51. Pharmacological and functional characterization of human mineralocorticoid and glucocorticoid receptor ligands
52. Target tissue specificity of mineralocorticoids
53. 11Beta-Hydroxysteroid dehydrogenase in the brain: A novel regulator of glucocorticoid action?
54. Relative occupation of type-I and type-II corticosteroid receptors in rat brain following stress and dexamethasone treatment: Functional implications
55. Evidence for reset of regulated cortisol in pregnancy: Studies in adrenalectomized ewes
56. Differential effects of pregnancy on mineralocorticoid and glucocorticoid receptor availability and immunoreactivity in cortisol feedback sites
57. Diurnal salivary cortisol patterns during pregnancy and after delivery: Relationship to plasma corticotrophin-releasing-hormone
58. Demonstration of an antiglucocorticoid action of progesterone on the corticosterone inhibition of beta-endorphin release by rat anterior pituitary in primary culture
59. The influence of ovarian steroids on hypothalamic-pituitary-adrenal regulation in the female rat
60. Structure-activity relationship of various corticosteroids on the feedback control of corticotrophin secretion
61. Steroid, corticotropin-releasing hormone, ACTH, and prostaglandin interactions in the amnion and placenta of early pregnancy in man
62. Presence of corticotropin in human placenta: Demonstration of in vitro synthesis
63. Expression and regulation of proopiomelanocortin-like gene in the ovary and placenta: Comparison with the testis
64. Three mRNA transcripts of the proopiomelanocortin gene in human placenta at term
65. Pro-opiomelanocortin in human pregnancy: Evolution of maternal plasma levels, concentrations in cord blood, amniotic fluid and at the feto-maternal interface
66. Placental corticotropin-releasing factor: An update
67. Putative role of placental corticotropin-releasing factor in the mechanisms of human parturition
68. Current topic: The placental corticotrophin-releasing hormone-adrenocorticotrophin axis
69. Alterations in the hypothalamic pituitary adrenal axis during pregnancy and the placental clock that determines the length of parturition
70. Plasma corticotropin-releasing hormone concentrations during pregnancy and parturition
71. Immunoreactive corticotropin-releasing hormone, adrenocorticotropin and cortisol in human plasma during pregnancy and delivery and postpartum
72. Characterization and gestational regulation of corticotropin-releasing hormone messenger RNA in human placenta
73. Immunoreactive corticotropin-releasing hormone in human plasma during pregnancy, labor, and delivery
74. Corticotropin-releasing hormone and oxytocin stimulate the release of placental proopiomelanocortin peptides
75. Corticotropin-releasing hormone in baboon pregnancy
76. Corticotropin-releasing factor-binding protein is a glycoprotein
77. Specific high-affinity binding protein for human corticotropin-releasing hormone in normal human plasma
78. Placental corticotropin-releasing hormone and the hypercortisolism of pregnancy
79. Measurement of corticotropin-releasing factor (CRF), CRF-binding protein (CRF-BP), and CRF/CRF-BP complex in human plasma by two-site enzyme-linked immunoabsorbant assay
80. Plasma GHRH, CRH, ACTH, beta-endorphin, human placental lactogen, GH and cortisol concentrations at the third trimester of pregnancy
81. Effect of betamethasone in vivo on placental corticotropin-releasing hormone in human pregnancy
82. Effects of betamethasone on maternal plasma corticotropin releasing factor, ACTH and cortisol during pregnancy
83. Steroids modulate corticotropin-releasing hormone production in human fetal membranes and placenta
84. Glucocorticoid stimulates expression of corticotropin-releasing hormone production in human fetal membranes and placenta
85. Corticotropin releasing hormone binding protein (CRH-BP): Plasma levels decrease during the third trimester of normal human pregnancy
86. The effect of pre-eclampsia on human placental corticotrophin-releasing hormone content and processing
87. Elevated levels of umbilical cord plasma corticotropin-releasing hormone in growth-retarded fetuses
88. Elevated maternal plasma corticotropin-releasing hormone levels in pregnancies complicated by preterm labor
89. Concentrations of corticotrophin-releasing hormone in the umbilical-cord blood of pregnancies complicated by pre-eclampsia
90. Maternal plasma and placental immunoreactive corticotrophin-releasing factor concentrations in infection-associated term and pre-term delivery
91. Corticotropin-releasing hormone in maternal and cord plasma in pre-eclampsia
92. Maternal corticotropin-releasing hormone is increased with impending preterm birth
93. Effect of corticotropin-releasing factor-binding protein on prostaglandin release from cultured maternal decidua and on contractile activity of human myometrium in vitro
94. Evidence for local stimulation of ACTH secretion by corticotrophin-releasing factor in human placenta
95. Human placenta and fetal membranes express human urocortin mRNA and peptide
96. Urocortin stimulates placental adrenocorticotropin and prostaglandin release and myometrial contractility in vitro
97. Corticotropin-releasing hormone-induced vasodilatation in the human fetal placental circulation
98. Endothelium-dependent and -independent mechanisms of vasorelaxation by corticotropin-releasing factor in pregnant rat uterine artery
99. A placental clock controlling the length of human pregnancy
100. Adrenocorticotropin causes vasodilatation in the human fetal-placental circulation
101. Corticotropin-releasing hormone-induced vasodilatation in the human fetal-placental circulation: Involvement of the nitric oxide-cyclic guanosine 3′,5′-monophosphate-mediated pathway
102. Production of corticotrophin releasing hormone by the sheep placenta in vivo
103. Induction of parturition by cortisol: Effects on negative feedback sensitivity and plasma CRE
104. Secretion of adrenocorticotrophin (ACTH) and ACTH precursors in ovine anterior pituitary cells: Actions of corticotrophin-releasing hormone, arginine vasopressin and glucocorticoids
105. Effect of adrenalectomy or long term cortisol or CRF infusion on the concentration and molecular weight distribution of ACTH in fetal sheep plasma
106. Role of vagosympathetic fibers in the control of adrenocorticotropic hormone, vasopressin, and renin responses to hemorrhage in fetal sheep
107. Hormonal and hemodynamic responses to vena caval obstruction in fetal sheep
108. Developmental changes in the responses of the adrenal glands of foetal sheep to endogenous adrenocorticotrophin, as indicated by hormone responses to hypoxaemia
109. Acidemia stimulates ACTH, vasopressin, and heart rate responses in fetal sheep
110. Development of adrenal cortical function
111. Prolonged pregnancy following surgical lesions of the foetal lamb pituitary
112. The mechanism of initiation of parturition in the ewe
113. Premature parturition after infusion of corticotrophin or cortisol into foetal lambs
114. Premature delivery of foetal lambs infused with glucocorticoids
115. Ovine placental steroid 17 alpha-hydroxylase/C-17,20-lyase, aromatase and sulphatase in dexamethasone-induced and natural parturition
116. The effects of dexamethasone on plasma steroid levels and fetal adrenal histology in the pregnant rhesus monkey
117. Regulation of prostaglandin endoperoxide H synthase 1 and 2 by estradiol and progesterone in nonpregnant ovine myometrium and endometrium in vivo
118. The oxytocin antagonist atosiban prevents androstenedione-induced myometrial contractions in the chronically instrumented, pregnant rhesus monkey
119. Regulation and function of the primate fetal adrenal gland and gonad
120. Endocrine functions of the human fetoplacental unit
121. Steroid production by definitive and fetal zones of the human fetal adrenal gland
122. Effect of bilateral lesions of the ovine fetal hypothalamic paraventricular nuclei at 118-122 days of gestation on subsequent adrenocortical steroidogenic enzyme gene expression
123. The effect of hypothalamic lesions on the length of gestation in fetal sheep
124. The effects of prostaglandins on ACTH secretion
125. Prostaglandin biosynthesis and catabolism in the developing fetal sheep brain
126. Ontogeny of immunoreactive prostaglandin endoperoxide synthase isoforms in ovine fetal pituitary, hypothalamus, and brainstem
127. Influence of estradiol and androstenedione on ACTH and cortisol secretion in the ovine fetus
128. Modulation of ovine fetal adrenocorticotropin secretion by androstenedione and 17beta-estradiol
129. Sensitivity of cortisol-induced inhibition of ACTH and renin in fetal sheep
130. Insensitivity of near-term fetal sheep to cortisol: Possible relation to the control of parturition
131. High levels of corticotropin-releasing hormone immunoreactivity in maternal and fetal plasma during pregnancy
132. Changes in amniotic fluid immunoreactive corticotropin-releasing factor (CRF) and CRF-binding protein levels in pregnant women at term and during labor
133. Corticotropin-releasing hormone in amniotic fluid during gestation and labor an in relation to fetal lung maturation
134. Corticotropin releasing hormone levels in human plasma and amniotic fluid during gestation
135. Transuteroplacental metabolism of cortisol and cortisone during mid- and late gestation in the baboon
136. Feto-maternal transfer and production of cortisol in sheep
137. The origin of cortisol in the blood of fetal sheep
138. Changes in concentrations of cortisol, dehydroepiandrosterone sulphate and progesterone in fetal and maternal serum during pregnancy
139. Adrenal corticosteroids and immunoreactive ACTH in chronically cannulated ovine foetuses with bilateral adrenalectomy
140. Can maternal stress alter fetal adrenocorticotropin secretion?
141. Negative-feedback inhibition of fetal ACTH secretion by maternal cortisol
142. Are fetal adrenocorticotropic hormone and renin secretion suppressed by maternal cortisol secretion?
143. Circadian rhythms in maternal plasma cortisol, estrone, estradiol, and estriol at 34 to 35 weeks' gestation
144. Immunohistochemical localization of the 11 beta-hydroxysteroid dehydrogenase type II enzyme in human kidney and placenta
145. Differential expression of 11 beta-hydroxysteroid dehydrogenase types 1 and 2 in human placenta and fetal membranes
146. Interconversion of cortisol and cortisone in the baboon placenta at midgestation: Expression of 11beta-hydroxysteroid dehydrogenase type 1 messenger RNA
147. Cortisol and cortisone levels in umbilical cord plasma and maternal plasma of normal pregnancies
148. Fetal heart rate, arterial pressure, and blood volume responses to cortisol infusion
149. Placental 11 beta-hydroxysteroid dehydrogenase and the programming of hypertension
150. Medical and physiological aspects of the 11beta-hydroxysteroid dehydrogenase system
151. The effects of dexamethasone on the peripheral plasma concentrations of androstenedione, testosterone and cortisol in the pregnant rhesus monkey
152. Effects of prolonged (48 h) infusion of cortisol on blood pressure, renal function and fetal fluids in the immature ovine foetus
153. Preterm betamethasone treatment of fetal sheep: Outcome after term delivery
154. Cushing syndrome in pregnancy
155. Maternal dexamethasone treatment in late gestation alters glucocorticoid and mineralocorticoid receptor mRNA in the fetal guinea pig brain
156. Perinatal treatment with glucocorticoids and the risk of maldevelopment of the brain
157. Addison's disease and pregnancy
158. Addison's disease and pregnancy
159. Maternal Addison's disease and fetal growth retardation: A case report
160. Schmidt's syndrome presenting with intrauterine growth retardation and postpartum addisonian crisis
161. Pregnancy and Addison's disease
162. Pregnancy in Addison's Disease
163. Pregnancy and adrenal insufficiency: Apropos of a case and reminder of management procedures
164. Addison's disease and pregnancy
165. Addisonian crisis in pregnancy: Case report
166. Complications after cesarean section in untreated Addison's disease
167. Addison's disease presenting as a crisis in the puerperium
168. Addison's disease presenting in the postpartum state
169. Sheep model for study of maternal adrenal gland function during pregnancy